Evaluation of serum ischemia-modified albumin levels in pregnant women with and without gestational diabetes mellitus

References

• Jovanovic L, Pettitt DJ. Gestational diabetes mellitus. JAMA 2001;286:2516–2518.
   PubMed Web of Science ®Google Scholar
• Dabelea D, Snell-Bergeon JK, Hartsfield CL, Bischoff KJ, Hamman RF, McDuffie RS; Kaiser Permanente of Colorado GDM Screening Program. Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: kaiser permanente of colorado GDM screening program. Diabetes Care 2005;28:579–584.
   PubMed Web of Science ®Google Scholar
• Kali Makedou, Anargyros Kourtis, Athina Gkiomisi, Konstantinos A. Toulis, Maria Mouzaki, et al. Oxidized low-density lipoprotein and adiponectin levels in pregnancy. Gynecol Endocrinol 2011;27:1070–1073.
   PubMed Web of Science ®Google Scholar
• Prefumo F, Gaze DC, Papageorghiou AT, Collinson PO, Thilaganathan B. First trimester maternal serum ischaemia-modified albumin: a marker of hypoxia-ischaemia-driven early trophoblast development. Hum Reprod 2007;22:2029–2032.
   PubMed Web of Science ®Google Scholar
• van Rijn BB, Franx A, Sikkema JM, van Rijn HJ, Bruinse HW, Voorbij HA. Ischemia modified albumin in normal pregnancy and preeclampsia. Hypertens Pregnancy 2008;27:159–167.
   PubMed Web of Science ®Google Scholar
• Guven S, Alver A, Mentese A, Ilhan FC, Calapoglu M, Unsal MA. The novel ischemia marker ‘ischemia-modified albumin’ is increased in normal pregnancies. Acta Obstet Gynecol Scand 2009;88:479–482.
   PubMed Web of Science ®Google Scholar
• Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med 2000;19:311–315.
   PubMed Web of Science ®Google Scholar
• da Silva SH, Hausen Bdos S, da Silva DB, Becker AM, de Campos MM, Duarte MM, Moresco RN. Characteristics of a nickel-albumin binding assay for assessment of myocardial ischaemia. Biomarkers 2010;15:353–357.
   PubMed Web of Science ®Google Scholar
• Hjortshøj S, Kristensen SR, Ravkilde J. Diagnostic value of ischemia-modified albumin in patients with suspected acute coronary syndrome. Am J Emerg Med 2010;28:170–176.
   PubMed Web of Science ®Google Scholar
• Ma SG, Xu W, Wei CL, Wu XJ, Hong B, Wang ZJ, Hao HR, Guo HQ. Role of ischemia-modified albumin and total homocysteine in estimating symptomatic lacunar infarction in type 2 diabetic patients. Clin Biochem 2011;44:1299–1303.
   PubMed Web of Science ®Google Scholar
• Apple FS, Wu AH, Mair J, Ravkilde J, Panteghini M, Tate J, Pagani F, et al. Committee on Standardization of Markers of Cardiac Damage of the IFCC. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem 2005;51:810–824.
   PubMed Web of Science ®Google Scholar
• Lappas M, Hiden U, Desoye G, Froehlich J, Hauguel-de Mouzon S, Jawerbaum A. The role of oxidative stress in the pathophysiology of gestational diabetes mellitus. Antioxid Redox Signal 2011;15:3061–3100.
   PubMed Web of Science ®Google Scholar
• López-Tinoco C, Roca M, García-Valero A, Murri M, Tinahones FJ, Segundo C, et al. Oxidative stress and antioxidant status in patients with late-onset gestational diabetes mellitus. Acta Diabetol 2011;53:S1–S556.
   Google Scholar
• Guven MA, Kilinc M, Batukan C, Ekerbicer HC, Aksu T. Elevated second trimester serum homocysteine levels in women with gestational diabetes mellitus. Arch Gynecol Obstet 2006;274:333–337.
   PubMedGoogle Scholar
• Tarim E, Yigit F, Kilicdag E, Bagis T, Demircan S, Simsek E, Haydardedeoglu B, Yanik F. Early onset of subclinical atherosclerosis in women with gestational diabetes mellitus. Ultrasound Obstet Gynecol 2006;27:177–182.
   PubMed Web of Science ®Google Scholar
• Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982;144:768–773.
   PubMed Web of Science ®Google Scholar
• Iacovidou N, Briana DD, Boutsikou M, Liosi S, Baka S, Boutsikou T, Hassiakos D, Malamitsi-Puchner A. Cord blood ischemia-modified albumin levels in normal and intrauterine growth restricted pregnancies. Mediators Inflamm 2008;2008:523081.
   PubMed Web of Science ®Google Scholar
• Boisvert MR, Koski KG, Skinner CD. Increased oxidative modifications of amniotic fluid albumin in pregnancies associated with gestational diabetes mellitus. Anal Chem 2010;82:1133–1137.
   PubMed Web of Science ®Google Scholar
• Karacay O, Sepici-Dincel A, Karcaaltincaba D, Sahin D, Yalvaç S, Akyol M, Kandemir O, Altan N. A quantitative evaluation of total antioxidant status and oxidative stress markers in preeclampsia and gestational diabetic patients in 24–36 weeks of gestation. Diabetes Res Clin Pract 2010;89:231–238.
   PubMed Web of Science ®Google Scholar
• Gelisgen R, Genc H, Kayali R, Oncul M, Benian A, Guralp O, Uludag S, et al. Protein oxidation markers in women with and without gestational diabetes mellitus: a possible relation with paraoxonase activity. Diabetes Res Clin Pract 2011;94:404–409.
   PubMed Web of Science ®Google Scholar
• Schneider S, Freerksen N, Röhrig S, Hoeft B, Maul H. Gestational diabetes and preeclampsia–similar risk factor profiles? Early Hum Dev 2012;88:179–184.
   PubMed Web of Science ®Google Scholar
• Rowan JA, Gao W, Hague WM, McIntyre HD. Glycemia and its relationship to outcomes in the metformin in gestational diabetes trial. Diabetes Care 2010;33:9–16.
   PubMed Web of Science ®Google Scholar
• Couch SC, Philipson EH, Bendel RB, Wijendran V, Lammi-Keefe CJ. Maternal and cord plasma lipid and lipoprotein concentrations in women with and without gestational diabetes mellitus. Predictors of birth weight? J Reprod Med 1998;43:816–822.
   PubMed Web of Science ®Google Scholar